Home › Medulloblastoma › District of Columbia
Medulloblastoma clinical trials in District of Columbia
7 studies for Medulloblastoma are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
- Children's National Hospital, Washington D.C.
RecruitingPhase 1/2
Ages 1 to 25 · All sexes · Updated Sep 28, 2026 · NCT07346157Digoxin Medulloblastoma Study
- Children's National Medical Center, Washington D.C.
RecruitingPhase 2
12 Months – 30 Years · All sexes · Updated Aug 26, 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Children's National Medical Center, Washington D.C.
RecruitingPhase 3
Ages 4 to 21 · All sexes · Updated Aug 25, 2026 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Children's National Medical Center, Washington D.C.
RecruitingPhase 2
Ages 3 to 39 · All sexes · Updated Aug 24, 2026 · NCT05096481Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
- Children's National Hospital, Washington D.C.
Recruiting
12 Months – 39 Years · All sexes · Updated Aug 11, 2026 · NCT05057702Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
- Children's National Hospital, Washington D.C.
RecruitingPhase 1
Ages 4 to 30 · All sexes · Updated Aug 7, 2026 · NCT06514898Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
- Children's National Hospital, Washington D.C.
RecruitingPhase 1
Ages 1 to 30 · All sexes · Updated Jun 17, 2026 · NCT06193759From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.